Citi Reiterates Buy Rating on Abbott Labs (ABT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Abbott Labs (ABT) PT Raised to $135 at JPMorgan
October 10, 2024 5:42 AM EDTJPMorgan analyst Robbie Marcus raised the price target on Abbott Labs (NYSE: ABT) to $135.00 (from $125.00) while maintaining a Overweight rating.
The analyst comments "Abbott is set to report 3Q24 results before the open on Wednesday, October 16. With volumes healthy, Fx modestly better, and price still a tailwind, we see... More
Oppenheimer Starts Abbott Labs (ABT) at Outperform
October 8, 2024 6:02 AM EDTOppenheimer analyst Suraj Kalia initiates coverage on Abbott Labs (NYSE: ABT) with a Outperform rating and a price target of $130.00.
The analyst comments "We are initiating coverage of Abbott Labs, a large-cap diversified healthcare play, with an OP... More
